AUPH - Aurinia Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5580.81M
Enterprise Value 3452.37M
Trailing P/E N/A
Forward P/E 1-11.47
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1,254.46
Price/Book (mrq)4.79
Enterprise Value/Revenue 3977.03
Enterprise Value/EBITDA 6-8.29

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,129.16%

Management Effectiveness

Return on Assets (ttm)-20.91%
Return on Equity (ttm)-46.08%

Income Statement

Revenue (ttm)463k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-3.30%
Gross Profit (ttm)463k
EBITDA -54.59M
Net Income Avi to Common (ttm)-64.12M
Diluted EPS (ttm)-0.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)125.86M
Total Cash Per Share (mrq)1.37
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)18.30
Book Value Per Share (mrq)1.32

Cash Flow Statement

Operating Cash Flow (ttm)-51.61M
Levered Free Cash Flow (ttm)-32.84M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.15
52-Week Change 316.28%
S&P500 52-Week Change 38.63%
52 Week High 37.85
52 Week Low 35.06
50-Day Moving Average 36.49
200-Day Moving Average 36.22

Share Statistics

Avg Vol (3 month) 3881.48k
Avg Vol (10 day) 3641.49k
Shares Outstanding 585.34M
Float 66.15M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Mar 29, 2019) 46.27M
Short Ratio (Mar 29, 2019) 47.1
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 46.96%
Shares Short (prior month Feb 28, 2019) 45.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Oct 23, 2013